^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
AmoyDx® Master Panel

Type:
Laboratory Developed Test
Related tests:

Details

Evidence
AmoyDx® Master Panel consists of 2660 onco-immunology genes. Functional enrichment of each sample is evaluated by single sample Gene Set Enrichment Analysis (ssGSEA) and pathway-level unsupervised clustering is conducted to identify molecular subtypes in METex14 skipping positive NSCLC patients.
Cancer:
Non Small Cell Lung Cancer
Gene:
MET (MET proto-oncogene, receptor tyrosine kinase)